According to the survey of enterprises, central enterprises include centrally invested companies and centrally managed enterprises. Sinopharm Holdings has equity financing fund management business, high-end pharmaceutical business, scientific research capability and professional service capability covering the whole country. Its field belongs to the management scope of central enterprises, and Sinopharm Holdings is a central enterprise.

The shareholders of Sinopharm Holdings are the State Council State-owned Assets Supervision and Administration Commission and China Pharmaceutical Group Company, both of which are state-owned enterprises at the central level. Sinopharm Holdings has the nature of central enterprises in the ownership structure.